Literature DB >> 23809411

Deep intronic 'mutations' cause hemophilia A: application of next generation sequencing in patients without detectable mutation in F8 cDNA.

B Pezeshkpoor1, N Zimmer, N Marquardt, I Nanda, T Haaf, U Budde, J Oldenburg, O El-Maarri.   

Abstract

BACKGROUND: In a small group of typical hemophilia A (HA) patients no mutations in the F8 coding sequence (cDNA) could be found. In the current study, we performed a systematic screening of genetic and non-genetic parameters associated with reduced FVIII:C levels in a group of mostly mild HA (only one moderate) patients with no detectable mutations in F8 cDNA.
METHODS: We determined FVIII and VWF activity and antigen levels and performed VWF-FVIII binding (VWF:FVIIIB) and VWF-collagen binding assays (VWF:CB) as well as VWF multimer analysis. VWF was completely sequenced to exclude mutations. The F8 locus, including the introns, was sequenced using overlapping long-range PCRs (LR-PCRs) combined with a next generation sequencing (NGS) approach. Moreover, the F8 mRNA was analyzed quantitatively and qualitatively by real-time PCR (qRT) and overlapping reverse transcription (RT) PCRs, respectively.
RESULTS: All VWF tests were normal. The LR-PCRs demonstrated the integrity of the F8 locus. Eight unique polymorphisms were found in the patients, with two being recurrent. Furthermore, RT-PCRs analysis confirmed that two of the unique variants create detectable new cryptic splice sites in the patients that result in the introduction of intronic DNA sequences into the mRNA and create premature stop codons.
CONCLUSION: By systematically excluding all possible causes of HA, we could with great certainty conclude that deep intronic mutations in F8, although rare, cause abnormal mRNA splicing, leading to mild HA.
© 2013 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  factor VIII; hemophilia A; introns; mRNA; mutations

Mesh:

Substances:

Year:  2013        PMID: 23809411     DOI: 10.1111/jth.12339

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  18 in total

Review 1.  Genetic testing in bleeding disorders.

Authors:  C de Brasi; O El-Maarri; D J Perry; J Oldenburg; B Pezeshkpoor; A Goodeve
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

Review 2.  Genomics of bleeding disorders.

Authors:  A C Goodeve; A Pavlova; J Oldenburg
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

3.  Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.

Authors:  B Boylan; A S Rice; C De Staercke; M E Eyster; H M Yaish; C M Knoll; C J Bean; C H Miller
Journal:  J Thromb Haemost       Date:  2015-05-09       Impact factor: 5.824

4.  Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.

Authors:  Jill M Johnsen; Shelley N Fletcher; Haley Huston; Sarah Roberge; Beth K Martin; Martin Kircher; Neil C Josephson; Jay Shendure; Sarah Ruuska; Marion A Koerper; Jaime Morales; Glenn F Pierce; Diane J Aschman; Barbara A Konkle
Journal:  Blood Adv       Date:  2017-05-18

Review 5.  Deep intronic mutations and human disease.

Authors:  Rita Vaz-Drago; Noélia Custódio; Maria Carmo-Fonseca
Journal:  Hum Genet       Date:  2017-05-12       Impact factor: 4.132

6.  Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites.

Authors:  Melissa Lee; Patrick Roos; Neeraj Sharma; Melis Atalar; Taylor A Evans; Matthew J Pellicore; Emily Davis; Anh-Thu N Lam; Susan E Stanley; Sara E Khalil; George M Solomon; Doug Walker; Karen S Raraigh; Briana Vecchio-Pagan; Mary Armanios; Garry R Cutting
Journal:  Am J Hum Genet       Date:  2017-05-04       Impact factor: 11.025

Review 7.  Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.

Authors:  B A Konkle; J M Johnsen; M Wheeler; C Watson; M Skinner; G F Pierce
Journal:  Haemophilia       Date:  2018-05       Impact factor: 4.287

8.  Reccurrent F8 Intronic Deletion Found in Mild Hemophilia A Causes Alu Exonization.

Authors:  Yohann Jourdy; Alexandre Janin; Mathilde Fretigny; Anne Lienhart; Claude Négrier; Dominique Bozon; Christine Vinciguerra
Journal:  Am J Hum Genet       Date:  2018-01-18       Impact factor: 11.025

Review 9.  Hemophilia B: molecular pathogenesis and mutation analysis.

Authors:  A C Goodeve
Journal:  J Thromb Haemost       Date:  2015-05-18       Impact factor: 5.824

10.  Small ncRNA Expression-Profiling of Blood from Hemophilia A Patients Identifies miR-1246 as a Potential Regulator of Factor 8 Gene.

Authors:  Tewarit Sarachana; Neetu Dahiya; Vijaya L Simhadri; Gouri Shankar Pandey; Surbhi Saini; Christine Guelcher; Michael F Guerrera; Chava Kimchi-Sarfaty; Zuben E Sauna; Chintamani D Atreya
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.